These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 1333719

  • 1. Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients.
    Charney DS, Woods SW, Krystal JH, Nagy LM, Heninger GR.
    Acta Psychiatr Scand; 1992 Oct; 86(4):273-82. PubMed ID: 1333719
    [Abstract] [Full Text] [Related]

  • 2. Endocrine, cardiovascular, and behavioral responses to clonidine in patients with panic disorder.
    Abelson JL, Glitz D, Cameron OG, Lee MA, Bronzo M, Curtis GC.
    Biol Psychiatry; 1992 Jul 01; 32(1):18-25. PubMed ID: 1391293
    [Abstract] [Full Text] [Related]

  • 3. Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks.
    Charney DS, Woods SW, Goodman WK, Heninger GR.
    Am J Psychiatry; 1987 Aug 01; 144(8):1030-6. PubMed ID: 3037926
    [Abstract] [Full Text] [Related]

  • 4. Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder.
    Charney DS, Heninger GR, Breier A.
    Arch Gen Psychiatry; 1984 Aug 01; 41(8):751-63. PubMed ID: 6742977
    [Abstract] [Full Text] [Related]

  • 5. Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder.
    Charney DS, Heninger GR.
    Arch Gen Psychiatry; 1986 Nov 01; 43(11):1042-54. PubMed ID: 3021083
    [Abstract] [Full Text] [Related]

  • 6. Effects of the serotonin reuptake inhibitor fluvoxamine on yohimbine-induced anxiety in panic disorder.
    Goddard AW, Woods SW, Sholomskas DE, Goodman WK, Charney DS, Heninger GR.
    Psychiatry Res; 1993 Aug 01; 48(2):119-33. PubMed ID: 8416022
    [Abstract] [Full Text] [Related]

  • 7. Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder.
    Coplan JD, Papp LA, Pine D, Martinez J, Cooper T, Rosenblum LA, Klein DF, Gorman JM.
    Arch Gen Psychiatry; 1997 Jul 01; 54(7):643-8. PubMed ID: 9236548
    [Abstract] [Full Text] [Related]

  • 8. Noradrenergic function in generalized anxiety disorder: effects of yohimbine in healthy subjects and patients with generalized anxiety disorder.
    Charney DS, Woods SW, Heninger GR.
    Psychiatry Res; 1989 Feb 01; 27(2):173-82. PubMed ID: 2540501
    [Abstract] [Full Text] [Related]

  • 9. Blunted growth hormone response to clonidine in patients with generalized anxiety disorder.
    Abelson JL, Glitz D, Cameron OG, Lee MA, Bronzo M, Curtis GC.
    Arch Gen Psychiatry; 1991 Feb 01; 48(2):157-62. PubMed ID: 1989571
    [Abstract] [Full Text] [Related]

  • 10. Noradrenergic responses to clonidine in acute and remitted depressed male patients.
    Trestman RL, Lawrence TL, Coccaro EF, Harvey P, Bernstein D, Lawrence EK, Condello V, Mahon T, Yang RK, Knott P.
    Psychiatry Res; 1992 Sep 01; 43(3):199-213. PubMed ID: 1332095
    [Abstract] [Full Text] [Related]

  • 11. Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine.
    Charney DS, Heninger GR, Redmond DE.
    Life Sci; 1983 Jul 04; 33(1):19-29. PubMed ID: 6865647
    [Abstract] [Full Text] [Related]

  • 12. Noradrenergic dysregulation during discontinuation of cocaine use in addicts.
    McDougle CJ, Black JE, Malison RT, Zimmermann RC, Kosten TR, Heninger GR, Price LH.
    Arch Gen Psychiatry; 1994 Sep 04; 51(9):713-9. PubMed ID: 8080348
    [Abstract] [Full Text] [Related]

  • 13. Abnormal noradrenergic function in posttraumatic stress disorder.
    Southwick SM, Krystal JH, Morgan CA, Johnson D, Nagy LM, Nicolaou A, Heninger GR, Charney DS.
    Arch Gen Psychiatry; 1993 Apr 04; 50(4):266-74. PubMed ID: 8466387
    [Abstract] [Full Text] [Related]

  • 14. Adrenergic status in anxiety disorders: platelet alpha 2-adrenergic receptor binding, blood pressure, pulse, and plasma catecholamines in panic and generalized anxiety disorder patients and in normal subjects.
    Cameron OG, Smith CB, Lee MA, Hollingsworth PJ, Hill EM, Curtis GC.
    Biol Psychiatry; 1990 Jul 01; 28(1):3-20. PubMed ID: 2165422
    [Abstract] [Full Text] [Related]

  • 15. Plasma 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) and growth hormone responses to yohimbine in panic disorder patients and normal controls.
    Gurguis GN, Uhde TW.
    Psychoneuroendocrinology; 1990 Jul 01; 15(3):217-24. PubMed ID: 2255749
    [Abstract] [Full Text] [Related]

  • 16. Alpha 2-adrenoreceptor status in obsessive-compulsive disorder.
    Lee MA, Cameron OG, Gurguis GN, Glitz D, Smith CB, Hariharan M, Abelson JL, Curtis GC.
    Biol Psychiatry; 1990 May 15; 27(10):1083-93. PubMed ID: 2160292
    [Abstract] [Full Text] [Related]

  • 17. Platelet alpha 2-adrenoreceptors, catecholamines, hemodynamic variables, and anxiety in panic patients and their asymptomatic relatives.
    Cameron OG, Smith CB, Nesse RM, Hill EM, Hollingsworth PJ, Abelson JA, Hariharan M, Curtis GC.
    Psychosom Med; 1996 May 15; 58(4):289-301. PubMed ID: 8827791
    [Abstract] [Full Text] [Related]

  • 18. alpha 2-Adrenergic receptor sensitivity in depression. The plasma MHPG, behavioral, and cardiovascular responses to yohimbine.
    Heninger GR, Charney DS, Price LH.
    Arch Gen Psychiatry; 1988 Aug 15; 45(8):718-26. PubMed ID: 2840050
    [Abstract] [Full Text] [Related]

  • 19. Differential effects of noradrenergic drugs on anxiety and arousal in healthy volunteers with high and low anxiety.
    Mizuki Y, Suetsugi M, Ushijima I, Yamada M.
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Nov 15; 20(8):1353-67. PubMed ID: 9004342
    [Abstract] [Full Text] [Related]

  • 20. Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects.
    Krystal JH, Webb E, Cooney NL, Kranzler HR, Southwick SW, Heninger GR, Charney DS.
    Am J Psychiatry; 1996 Jan 15; 153(1):83-92. PubMed ID: 8540598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.